These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 9693786

  • 1. Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development.
    Watanabe G, Pena P, Shambaugh GE, Haines GK, Pestell RG.
    Brain Res Dev Brain Res; 1998 Jun 15; 108(1-2):77-87. PubMed ID: 9693786
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical examination of the INK4 and Cip inhibitors in the rat neonatal cerebellum: cellular localization and the impact of protein calorie malnutrition.
    Shambaugh GE, Haines GK, Koch A, Lee EJ, Zhou Jn, Pestell R.
    Brain Res; 2000 Feb 07; 855(1):11-22. PubMed ID: 10650125
    [Abstract] [Full Text] [Related]

  • 3. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE, Xiong Y.
    Cell Growth Differ; 1998 Aug 07; 9(8):595-610. PubMed ID: 9716177
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
    Parry D, Mahony D, Wills K, Lees E.
    Mol Cell Biol; 1999 Mar 07; 19(3):1775-83. PubMed ID: 10022865
    [Abstract] [Full Text] [Related]

  • 6. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.
    Chellappan SP, Giordano A, Fisher PB.
    Curr Top Microbiol Immunol; 1998 Mar 07; 227():57-103. PubMed ID: 9479826
    [No Abstract] [Full Text] [Related]

  • 7. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D.
    Oncogene; 1999 May 06; 18(18):2798-810. PubMed ID: 10362250
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M, Muller WJ, Singh G, Graham FL.
    Oncogene; 1999 Mar 04; 18(9):1663-76. PubMed ID: 10208428
    [Abstract] [Full Text] [Related]

  • 9. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
    Koh KN, Kang MJ, Frith-Terhune A, Park SK, Kim I, Lee CO, Koh GY.
    J Mol Cell Cardiol; 1998 Mar 04; 30(3):463-74. PubMed ID: 9515024
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A potential role for p15(Ink4b) and p57(Kip2) in liver development.
    Awad MM, Sanders JA, Gruppuso PA.
    FEBS Lett; 2000 Oct 20; 483(2-3):160-4. PubMed ID: 11042273
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M.
    Hepatology; 2001 May 20; 33(5):1087-97. PubMed ID: 11343236
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.